BSBE has teamed up with National Pharmaceutical Investment to acquire MXB for $371 million. In a separate development, new material company Mingxun Hi-Tech Material Joint-Stock has raised ‘tens of millions of US dollars’ in a new funding round from Fosun, Addor Capital and Cowin Capital.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
